Fears over GP access to drug bulletin
GPs' future access to the respected evidence review journal Drug and Therapeutics Bulletin is in jeopardy.
The Department of Health which currently pays for the journal through a central contract is debating whether to renew its funding, which expires in April.
There are fears the current arrangement may be replaced by local purchasing, which could threaten access.
Dr Ike Iheanacho, DTB editor, said: 'If there was no longer a central contract the options might be local procuring, but that would be difficult for users and for us. It would ultimately cost the NHS more money and something doctors were relying on they could no longer be sure of getting.'
Questions about the renewal have been raised in Parliament.
Lord Harris of Haringey asked health minister Lord Warner: 'Is he aware the consequence of a failure to take a decision or to cease central funding will be the most grotesque false economy?'